Eli Lilly and Co (NYSE:LLY)
| 445.62 Delayed Data As of 4:00pm ET |  +9.25 / +2.12%Today’s Change | 283.11 Today|||52-Week Range 454.95 | +21.81% Year-to-Date |
Latest LLY News | Press Releases
Today’s Trading
| Previous close | 436.37 |
| Today’s open | 435.51 |
| Day’s range | 433.15 - 447.45 |
| Volume | 2,040,858 |
| Average volume (3 months) | 3,263,109 |
| Market cap | $419.9B |
Data as of 4:00pm ET, 06/08/2023
Growth & Valuation
| Earnings growth (last year) | +12.53% |
| Earnings growth (this year) | +9.35% |
| Earnings growth (next 5 years) | +24.20% |
| Revenue growth (last year) | +0.79% |
| P/E ratio | 70.9 |
| Price/Sales | 11.60 |
| Price/Book | 39.46 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| JNJJohnson & Johnson | +1.75 | +1.10% |
| MRKMerck | +1.72 | +1.58% |
| NVONovo Nordisk | +1.95 | +1.24% |
| ABBVAbbVie | +1.15 | +0.84% |
Data as of 4:00pm ET, 06/08/2023
Financials
| Next reporting date | August 8, 2023 |
| EPS forecast (this quarter) | $1.99 |
| Annual revenue (last year) | $28.5B |
| Annual profit (last year) | $6.2B |
| Net profit margin | 21.88% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Indianapolis, Indiana |
Forecasts
